Racial/ethnic-based spirometry reference equations: Are they accurate for admixed populations?

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by the Sandler Family Foundation; the American Asthma Foundation; the RWJF Amos Medical Faculty Development Program; Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II; the National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL117004, 1X01HL134589, R01HL128439, R01HL135156, R01HL141992]; the National Institute of Environmental Health Sciences [R01ES015794, R21ES24844]; the National Institute on Minority Health and Health Disparities [R01MD010443, R56MD013312]; the National Human Genome Research Institute [U01HG009080]; the National Institute of General Medical Sciences [T32GM007546], and the UCSF Pediatric Allergy, Immunology, and Bone Marrow Transplantation Division. The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data in the present work comes from two multicenter asthma case-control studies: the Genes-environments and Admixture in Latino Americans (GALA II) Study and the Study of African Americans, Asthma, Genes, and Environments (SAGE II). GALA II (IRB # 10-00889, reference # 310512) and SAGE II (IRB # 10-02877, reference # 302402) were organized from the coordinating center based at the University of California, San Francisco. Subjects were recruited from 5 urban study centers across the mainland United States and Puerto Rico. All participants provided written consent to being in the study. Consent was obtained from all participants 18-years and older and parent/legal guardians of minor participants. The study protocols for both GALA II and SAGE were approved by the University of California, San Francisco (UCSF) Human Research Protection Program Institutional Review Board (IRB) and all institutions participating in recruitment obtained the appropriate approvals from their IRBs for recruitment related activity.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes